• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Prudential Jennison Health Sciences Fund

+ Add to Watchlist

PHLCX:US

37.49 USD 0.16 0.43%

As of 09:29:30 ET on 07/11/2014.

Snapshot for Prudential Jennison Health Sciences Fund (PHLCX)

Year To Date: +8.42% 3-Month: +12.75% 3-Year: +25.78% 52-Week Range: 29.54 - 41.50
1-Month: +1.19% 1-Year: +24.95% 5-Year: +27.17% Beta vs SPR: 0.98

Mutual Fund Chart for PHLCX

No chart data available.
  • PHLCX:US 37.49
  • 1M
  • 1Y
Interactive PHLCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHLCX

Prudential Jennison Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of assets plus borrowings for investment purposes in securities of companies in the health sciences sector, such as pharmaceutical, biotechnology and healthcare service providers.

Inception Date: 06-30-1999 Telephone: 1-800-225-1852
Managers: DAVID CHAN / MICHAEL DEL BALSO
Web Site: www.prudentialfunds.com

Fundamentals for PHLCX

NAV (on 2014-07-11) 37.49
Assets (M) (on 2014-05-30) 2,323.15
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 100.00

Dividends for PHLCX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2013-12-17) 0.54
Dividend Yield (ttm) 8.61

Fees & Expenses for PHLCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.73
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 1.88

Top Fund Holdings for PHLCX

Filing Date: 05/31/2014
Name Position Value % of Total
Alexion Pharmaceuticals Inc 722,477 120,162,375 5.173%
BioMarin Pharmaceutical Inc 1,752,708 101,586,956 4.373%
Vertex Pharmaceuticals Inc 1,287,498 93,034,605 4.005%
Roche Holding AG 287,488 84,737,793 3.648%
Biogen Idec Inc 254,068 81,141,697 3.493%
Incyte Corp Ltd 1,607,959 79,674,368 3.430%
HCA Holdings Inc 1,356,472 71,879,451 3.094%
Merck & Co Inc 1,110,321 64,243,173 2.766%
Bristol-Myers Squibb Co 1,290,354 64,182,208 2.763%
Intercept Pharmaceuticals Inc 261,624 61,902,855 2.665%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil